STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and delivery systems to deliver the lenses into the eye. The company provides Visian implantable collamer lenses (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness.
Read More…
Industry, Sector and Symbol
Industry Ophthalmic goods
Sub-IndustryHealth Care Supplies
SectorMedical
Phone626-303-7902
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$123.95 million
Profitability
Miscellaneous
Employees475
Next Earnings Date10/30/2019 (Confirmed)
OptionableOptionable
STAAR Surgical (NASDAQ:STAA) Frequently Asked Questions
What is STAAR Surgical's stock symbol?
STAAR Surgical trades on the NASDAQ under the ticker symbol "STAA."
How were STAAR Surgical's earnings last quarter?
STAAR Surgical (NASDAQ:STAA) announced its earnings results on Wednesday, July, 31st. The medical instruments supplier reported $0.14 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.10 by $0.04. The medical instruments supplier had revenue of $39.66 million for the quarter, compared to analyst estimates of $40.10 million. STAAR Surgical had a net margin of 5.80% and a return on equity of 12.81%. View STAAR Surgical's Earnings History.
When is STAAR Surgical's next earnings date?
How can I listen to STAAR Surgical's earnings call?
STAAR Surgical will be holding an earnings conference call on Wednesday, October 30th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.
What price target have analysts set for STAA?
1 brokerages have issued 12 month price objectives for STAAR Surgical's stock. Their forecasts range from $38.00 to $38.00. On average, they expect STAAR Surgical's share price to reach $38.00 in the next twelve months. This suggests a possible upside of 38.7% from the stock's current price. View Analyst Price Targets for STAAR Surgical.
What is the consensus analysts' recommendation for STAAR Surgical?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for STAAR Surgical in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for STAAR Surgical.
Has STAAR Surgical been receiving favorable news coverage?
News stories about STAA stock have been trending negative this week, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of news coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. STAAR Surgical earned a news impact score of -2.8 on InfoTrie's scale. They also gave news headlines about the medical instruments supplier a news buzz of 9.0 out of 10, meaning that recent news coverage is extremely likely to have an impact on the stock's share price in the near future. View News Stories for STAAR Surgical.
Who are some of STAAR Surgical's key competitors?
Some companies that are related to STAAR Surgical include Align Technology (ALGN), Cooper Companies (COO), DENTSPLY SIRONA (XRAY), West Pharmaceutical Services (WST), Haemonetics (HAE), Neogen (NEOG), ICU Medical (ICUI), Quidel (QDEL), Merit Medical Systems (MMSI), Atrion (ATRI), Anika Therapeutics (ANIK), Cerus (CERS), Antares Pharma (ATRS), OraSure Technologies (OSUR) and Meridian Bioscience (VIVO).
What other stocks do shareholders of STAAR Surgical own?
Who are STAAR Surgical's key executives?
STAAR Surgical's management team includes the folowing people:
- Ms. Caren L. Mason, CEO, Pres & Director (Age 65)
- Ms. Deborah J. Andrews, Chief Financial Officer (Age 62)
- Dr. Keith Holliday, Chief Technology Officer (Age 56)
- Mr. Samuel J. Gesten, Chief Legal Officer & Corp. Sec. (Age 57)
- Mr. Hans-Martin Blickensdoerfer, Sr. VP of Commercial Operations, Direct Markets- Europe & China (Age 54)
Who are STAAR Surgical's major shareholders?
STAAR Surgical's stock is owned by a number of of institutional and retail investors. Top institutional investors include Defender Capital LLC. (1.31%), KAMES CAPITAL plc (0.25%), Envestnet Asset Management Inc. (0.06%), CIBC Private Wealth Group LLC (0.04%) and Dfpg Investments Inc. (0.03%). Company insiders that own STAAR Surgical stock include Broadwood Partners, LP, Caren L Mason, Deborah J Andrews, Keith Holliday, Samuel J Gesten and William P Wall. View Institutional Ownership Trends for STAAR Surgical.
Which major investors are selling STAAR Surgical stock?
STAA stock was sold by a variety of institutional investors in the last quarter, including Defender Capital LLC., CIBC Private Wealth Group LLC and KAMES CAPITAL plc. Company insiders that have sold STAAR Surgical company stock in the last year include Caren L Mason, Deborah J Andrews, Keith Holliday and Samuel J Gesten. View Insider Buying and Selling for STAAR Surgical.
Which major investors are buying STAAR Surgical stock?
How do I buy shares of STAAR Surgical?
Shares of STAA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is STAAR Surgical's stock price today?
One share of STAA stock can currently be purchased for approximately $27.40.
How big of a company is STAAR Surgical?
STAAR Surgical has a market capitalization of $1.22 billion and generates $123.95 million in revenue each year. The medical instruments supplier earns $4.97 million in net income (profit) each year or $0.28 on an earnings per share basis. STAAR Surgical employs 475 workers across the globe.View Additional Information About STAAR Surgical.
What is STAAR Surgical's official website?
How can I contact STAAR Surgical?
STAAR Surgical's mailing address is 25651 ATLANTIC OCEAN DRIVE, LAKE FOREST CA, 92630. The medical instruments supplier can be reached via phone at 626-303-7902 or via email at [email protected]
MarketBeat Community Rating for STAAR Surgical (NASDAQ STAA)
MarketBeat's community ratings are surveys of what our community members think about STAAR Surgical and other stocks. Vote "Outperform" if you believe STAA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe STAA will underperform the S&P 500 over the long term. You may vote once every thirty days.
